Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vaxxinity Inc.

    OTC: VAXX · Real-Time Price · USD
    0.05
    0.02 (99.60%)
    At close: Mar 26, 2025, 2:50 PM

    Vaxxinity Statistics

    Share Statistics

    Vaxxinity has 126.78M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 126.78M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.21%

    Shares Floating

    n/a
    		 55.62M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 4.22M, so undefined% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.22M

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 7.59%

    Short Ratio (days to cover)

    n/a
    		 13.97

    Valuation Ratios

    The PE ratio is -1.89 and the forward PE ratio is null. Vaxxinity's PEG ratio is 0.08.

    PE Ratio

    n/a
    		 -1.89

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.01

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0.08
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Vaxxinity.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.89, with a Debt / Equity ratio of 1.13.

    Current Ratio

    n/a
    		 1.89

    Quick Ratio

    n/a
    		 1.89

    Debt / Equity

    n/a
    		 1.13

    Debt / EBITDA

    n/a
    		 -270.61

    Debt / FCF

    n/a
    		 -0.26

    Interest Coverage

    n/a
    		 -83.74

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-998.84

    Employee Count

    n/a
    		 57

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -56.93K

    Effective Tax Rate

    n/a
    		 100%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 1.07, so Vaxxinity's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.07

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.01

    200-Day Moving Average

    n/a
    		 0.04

    Relative Strength Index (RSI)

    n/a
    		 47.47

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -2.23M

    Operating Income

    n/a
    		 -58.28M

    Net Income

    n/a
    		 -56.93K

    EBITDA

    n/a
    		 -56.05K

    EBIT

    n/a
    		 639.07K

    Earnings Per Share (EPS)

    n/a
    		 -0.45
    Full Income Statement

    Balance Sheet

    The company has 5.04M in cash and 15.17M in debt, giving a net cash position of -10.13M.

    Cash & Cash Equivalents

    n/a
    		 5.04M

    Total Debt

    n/a
    		 15.17M

    Net Cash

    n/a
    		 -10.13M

    Retained Earnings

    n/a
    		 -361.64M

    Total Assets

    n/a
    		 44.31M

    Working Capital

    n/a
    		 15.63M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -57.24M and capital expenditures -803K, giving a free cash flow of -58.04M.

    Operating Cash Flow

    n/a
    		 -57.24M

    Capital Expenditures

    n/a
    		 -803K

    Free Cash Flow

    n/a
    		 -58.04M

    FCF Per Share

    n/a
    		 -458.79
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    VAXX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for VAXX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -15.14

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist